CHAPIN DAVIS, INC.

Position in LCTX — Lineage Cell Therapeutics, Inc.

CIK 872098 BALTIMORE, MD

Position in LCTX

as of Jun 30, 2026 · filed Jul 7, 2026 Compact

Position Value

$26,237

-$5,408 QoQ

Shares Held

20,029

0.0% QoQ

Ownership

0.008%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

of 9 holders

Holding Since

Mar 2025

6 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

CHAPIN DAVIS, INC. holds $1,662,100 across 5 Biotechnology names. LCTX ranks #5 (1.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	DYAI	Dyadic International Inc	888,004	$799,203
2	TRVI	Trevi Therapeutics, Inc.	20,100	$374,865
3	ALNY	Alnylam Pharmaceuticals, Inc.	850	$255,875
4	BEAM	Beam Therapeutics Inc.	6,000	$205,920
5	LCTX	Lineage Cell Therapeutics, Inc. This page	20,029	$26,237

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$26,237	20,029	0.0%	Shares	Sole	2026-07-07
2026-03-31	$31,645	20,029	0.0%	Shares	Sole	2026-04-21
2025-12-31	$33,448	20,029	0.0%	Shares	Sole	2026-01-30
2025-09-30	$33,849	20,029	0.0%	Shares	Sole	2025-10-09
2025-06-30	$18,226	20,029	0.0%	Shares	Sole	2025-07-14
2025-03-31	$9,013	20,029	—	Shares	Sole	2025-04-23
No filing history on record for this holder in this stock.